#DiabetesDialogue
LightNews LightNews
hcplivenews.bsky.social
Discover how the CATALYST trial reveals mifepristone's potential to enhance glycemic control and weight loss in challenging type 2 diabetes cases in the latest #DiabetesDialogue!

www.hcplive.com/view/diabete...
June 23, 2025 at 8:47 PM
hcplivenews.bsky.social
Discover the latest findings on tirzepatide vs semaglutide for #obesity from SURMOUNT-5 in the latest #DIabetesDIalogue with @dianamisaacs.bsky.social and Natalie Bellini!

Watch now: www.hcplive.com/view...
Diabetes Dialogue: Tirzepatide vs Semaglutide for Obesity, Understanding SURMOUNT-5
Discover the latest findings on tirzepatide vs semaglutide for obesity treatment, highlighting significant weight loss results & clinical insights.
www.hcplive.com
May 13, 2025 at 2:00 PM
hcplivenews.bsky.social
In this #DiabetesDialogue, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, are joined by Roy Beck, MD, PhD, to discuss the INHALE-3 trial, evaluating technosphere inhaled insulin (Afrezza) in comparison to standard diabetes therapies.

🔗 www.hcplive.com/view...

#Endocrinology #Podcast
Diabetes Dialogue: INHALE-3 Trial and Afrezza, With Roy Beck, MD, PhD
In this episode, hosts explore technosphere inhaled insulin (Afrezza) in comparison to standard diabetes therapies in the INHALE-3 trial.
www.hcplive.com
May 29, 2025 at 10:00 AM
hcplivenews.bsky.social
In this episode of #DiabetesDialogue, hosts @dianamisaacs and Natalie Bellini, DNP, sit down with John Sjolund and Jon Brilliant, co-founders of Luna Diabetes, to discuss the company's wearable patch pump that automates dosing of insulin during sleep.

🔗 www.hcplive.com/view...

#Podcasts
Diabetes Dialogue: Luna Automated Insulin Delivery, With Jon Brilliant and John Sjölund
Hosts explore Luna Diabetes automated insulin delivery system, designed to enhance sleep and improve glucose control for people with diabetes who use pens.
www.hcplive.com
May 15, 2025 at 10:00 AM
hcplivenews.bsky.social
As data for both agents continues to emerge, how do clinicians choose between semaglutide and tirzepatide for patients?

Get a breakdown in the latest #DiabetesDialogue with @DianaMIsaacs and @Natalie_Bellini: www.hcplive.com/view/diabete...

#Diabetes
September 8, 2025 at 9:00 PM
hcplivenews.bsky.social
Semaglutide 2.4 mg has received approval for MASH.

In April, #DiabetesDialogue recorded a special edition episode on the ESSENCE trial with Dr. Arun Sanyal.

www.hcplive.com/view/diabete...

#Hepatology #LiverTwitter
August 18, 2025 at 9:15 PM
hcplivenews.bsky.social
Check out the latest #DiabetesDialogue where @DianaMIsaacs and @Natalie_Bellini react to topline data from the SURPASS-CVOT trial of tirzepatide.

Learn more: www.hcplive.com/view/diabete...

#T2D #Type2Diabetes
August 5, 2025 at 11:23 PM
hcplivenews.bsky.social
The countdown to #ADA2025 is officially on! Get ready with a rundown from the #DiabetesDialogue crew before heading off to Chicago: www.hcplive.com/view...
Diabetes Dialogue: ADA 2025 Preview
In this special episode, cohosts preview the most anticipated data and explore clinical implications in diabetes and obesity.
www.hcplive.com
June 14, 2025 at 12:00 PM
hcplivenews.bsky.social
In this episode of #DiabetesDialogue, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, review notable sessions, emerging clinical insights, and advances in diabetes care from #AACE2025.

🔗 www.hcplive.com/view/diabete...

#Diabetes #Endocrinology
May 27, 2025 at 9:09 PM
hcplivenews.bsky.social
In the latest episode of #DiabetesDialogue, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, explore the real-world impact of @BetaBionics iLet Bionic Pancreas automated insulin delivery system with Steven Russell, MD, PhD.

🔗 www.hcplive.com/view...

#Diabetes #Endocrinology
Diabetes Dialogue: Real-World Impact of iLet Bionic Pancreas, With Steven Russell, MD, PhD
In this episode, hosts explore real-world data on Beta Bionics' iLet automated insulin delivery system for diabetes management.
www.hcplive.com
May 22, 2025 at 2:00 PM
hcplivenews.bsky.social
Check out the latest episode of #DiabetesDialogue, where hosts Diana Isaacs, PharmD, and @Natalie Bellini, DNP, discuss Luna Diabetes' overnight, wearable patch pump that automates dosing of insulin during sleep.

🔗 www.hcplive.com/view...

#Diabetes #Podcasts
Diabetes Dialogue: Luna Automated Insulin Delivery, With Jon Brilliant and John Sjölund
Hosts explore Luna Diabetes automated insulin delivery system, designed to enhance sleep and improve glucose control for people with diabetes who use pens.
www.hcplive.com
May 18, 2025 at 12:00 AM
hcplivenews.bsky.social
In the latest #DiabetesDialogue, hosts tackle key updates on CGM systems for diabetes, including the Dexcom G7, Freestyle Libre App, and Medtronic Simplera Sync.

Watch/Listen: www.hcplive.com/view...

#Diabetes #Endocrinology
Diabetes Dialogue: Dexcom G7, Libre App, and Medtronic Simplera Sync
In this episode, hosts explore updates on continuous glucose monitoring (CGM) systems from April 2025.
www.hcplive.com
May 10, 2025 at 3:00 PM
hcplivenews.bsky.social
What does the latest trial on semaglutide 2.4 mg mean for the medical community?

Hear from lead investigator Arun Sanyal, MD, in the latest #DiabetesDialogue
May 2, 2025 at 8:55 PM
hcplivenews.bsky.social
ICYMI: The ESSENCE trial evidenced semaglutide's benefit in MASH.

#DiabetesDialogue breaks down the trial and what it means for patients:

#Hepatology
May 1, 2025 at 8:59 PM
hcplivenews.bsky.social
In the latest #DiabetesDialogue, hosts explore the newly published data from CATALYST, examining the prevalence of hypercortisolism among individuals with difficult-to-control #Type2Diabetes.

🔗 www.hcplive.com/view...

#Podcasts
April 30, 2025 at 10:00 AM
hcplivenews.bsky.social
In the latest #DiabetesDialogue, Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the topline results from the ACHIEVE-1 trial evaluating oral orforglipron for adults with type 2 diabetes inadequately controlled by diet and exercise.

🔗 www.hcplive.com/view/diabete...

#Diabetes
April 24, 2025 at 9:07 PM
hcplivenews.bsky.social
The latest #DiabetesDialogue takes a deep dive into 2 studies from #ACC25, hear from @DianaMIsaacs and @Natalie_Bellini on how these impact decision-making in clinical practice: www.hcplive.com/view/diabete...
April 17, 2025 at 8:58 PM
hcplivenews.bsky.social
Check out the latest #DiabetesDialogue with @DIanaMIsaacs and @Natalie_Bellini as they break down a pair of studies from #ACC25!
April 16, 2025 at 9:00 PM
hcplivenews.bsky.social
In the latest #DiabetesDialogue, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, are joined by Rifka Schulman-Rosenbaum, MD, to explore the increasing clinical momentum behind screening for pre-symptomatic #T1D.

🔗 www.hcplive.com/view...
Diabetes Dialogue: Screening for Presymptomatic T1D with Rifka Schulman-Rosenbaum, MD
In this episode, experts discuss practical guidance for screening for presymptomatic type 1 diabetes with Rifka Schulman-Rosenbaum, MD.
www.hcplive.com
April 16, 2025 at 10:00 AM
hcplivenews.bsky.social
Our latest #DiabetesDialogue tackles the results of SOUL and STRIDE from #ACC25.

Learn more: www.hcplive.com/view...
Diabetes Dialogue: SOUL and STRIDE Trials from ACC 2025
In this episode, hosts break down the STRIDE and SOUL trials presented at the American College of Cardiology 2025 Annual Scientific Sessions.
www.hcplive.com
April 13, 2025 at 12:00 PM
hcplivenews.bsky.social
The latest episode of #DiabetesDialogue tackles updates on semaglutide from the STRIDE and SOUL trials at #ACC25.

Listen as Dr. Bellini discusses semaglutide's benefit on walking distance in patients with type 2 diabetes and PAD.

www.hcplive.com/view...
Diabetes Dialogue: SOUL and STRIDE Trials from ACC 2025
In this episode, hosts break down the STRIDE and SOUL trials presented at the American College of Cardiology 2025 Annual Scientific Sessions.
www.hcplive.com
April 11, 2025 at 10:00 AM
hcplivenews.bsky.social
Discover how the Omnipod 5 simplifies insulin management with meal presets & A1C data insights in the latest #DiabetesDialogue with Drs. Diana Isaacs and Natalie Bellini now:

#DiabetesCare #Type2Diabetes

www.hcplive.com/view...
Diabetes Dialogue: Omnipod 5 and Medtronic 780G for Type 2 Diabetes
In this episode, hosts offer perspective on recent studies assessing insulin delivery systems in adults with type 2 diabetes.
www.hcplive.com
February 21, 2025 at 9:42 PM
hcplivenews.bsky.social
In this episode of #DiabetesDialogue, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, FNP, explore the updated @AmDiabetesAssn 2025 Standards of Care, focusing on therapeutic innovations and the impact on diabetes management. #DiabetesCare #Podcasts

🔗 www.hcplive.com/view/diabete...
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Therapeutics
In this episode, hosts explore the latest updates to the ADA Standards of Care on therapeutic innovations and their real-world impact on diabetes management.
www.hcplive.com
January 24, 2025 at 6:00 PM
hcplivenews.bsky.social
In the latest episode of #DiabetesDialogue, hosts explore the optimization of insulin therapy using AI-driven algorithms with Eran Atlas, CEO of @DreaMedDiabetes.
🔗 www.hcplive.com/view/diabete...
Diabetes Dialogue: Leveraging Smart Algorithms for Insulin Optimization with Eran Atlas
In this episode, hosts discuss optimizing insulin therapy for people with diabetes using AI-driven algorithms with Eran Atlas, CEO of DreaMed Diabetes.
www.hcplive.com
January 8, 2025 at 10:05 PM